Ángela Carrión Antolí

Centre: Dpto. Bioquímica/IUI BIFI
Institution: University of Zaragoza, Zaragoza (Spain)
Position: PhD Student
E-mail: angelacarrionantoli@gmail.com
Phone: 976762989
Profile:  Ver 

Personal statement
I began my scientific career studying Biochemistry at the University of Murcia, where I graduated in 2020. Subsequently, I completed a Master’s degree in Biotechnology and Bioengineering at the Miguel Hernández University (2021). Currently, I am doing my doctoral thesis in Javier García Nafría’s group at the BIFI Institute, thanks to an FPI contract. I chose this center for its open laboratory concept, where interaction between different research groups is constant. This approach encourages shared access to scientific equipment and a wealth of ideas, as we work side by side with researchers from diverse lines. In addition, the team is made up of young Principal Investigators, which fosters an innovative and high-quality scientific environment, ideal for generating new perspectives and collaborations.

Mi perfil investigador
Currently, my EURAXESS level is R1 and I develop my research focused on the study of dopamine receptor bias. These receptors are key proteins in signal transmission in the brain, and their activation can generate different cellular responses depending on the ligand that activates them. “Receptor bias” refers to the ability of a ligand to selectively activate certain signaling pathways over others, allowing more specific responses. Understanding this phenomenon is crucial for the design of more effective therapies with fewer side effects in neurological disorders.

¿Por qué es importante lo que investigo?
My research focuses on understanding dopamine receptor bias, a field with great therapeutic potential. By studying how different ligands activate specific signaling pathways, I contribute to generating new hypotheses on how to modulate these receptors more selectively. This could improve the development of more effective drugs with fewer side effects to treat disorders such as schizophrenia or Parkinson’s.

The impact of my research on society is significant, as a better understanding of dopamine receptor bias could lead to more personalized and effective treatments, improving the quality of life of patients suffering from neurological disorders.

Know more about me and my research
– https://sites.google.com/view/signal-transduction-lab/homepage
– LinkedIn: Ángela Carrión Antolí
–Twitter/X: @angela31398
– Instagram: @angela31398